One of us (F.R.) recently reported a method allowing for the long-term culture of normal human T lymphocytes from peripheral blood or bone marrow (1) . Exponential proliferative growth was dependent upon the addition of a T-cell growth factor (TCGF) produced by phytohemagglutinin-stimulated normal human lymphocytes (1, 2) . We have used similar methodology and have reported the long-term culture of murine tumor-antigen specific cytotoxie T-cell lines (CTLL) (3) . Murine CTLL have remained in culture for over 20 mo during which time they have continued to mediate syngeneic tumor-specific cytotoxic reactivity. Both of the above mentioned observations involving the continuous culture of normal human and differentiated murine CTLL have been confirmed (4, 5) .
We now report the ability to culture large numbers of human antigen-specific cytotoxic T lymphocytes in a TCGF-dependent state of sustained exponential proliferation. This technological advance should allow for the performance of studies that were previously not possible, such as the characterization of cytotoxic T-cell differentiation markers, the molecular mechanism of lymphocyte-mediated cytolysis (LMC), and the nature of the T-ceU antigen receptor. In addition, human (H)-CTLL may provide a new tool for the typing of cell surface antigens; as well as provide new insight into the immunotherapeutic manipulation of several disease states, most notably: immunodeficiency, autoimmunity, and the host's response to malignancy.
Materials and Methods
In Vitro Generation and Long-Term Culture of H-CTLL. Antigen-specific cytotoxic T cells were generated in 7 day primary or 10 day secondary one-way mixed lymphocyte culture (MLC). Both responder and stimulator lymphocyte populations were isolated from normal human peripheral blood by Ficoll-Hypaque sedimentation (6) and diluted to 1 × 10 e eells/ml in RPMI-1640 supplemented with 10% heat-inactivated fetal calf serum, Grand Island Biological Co., Grand Island, N. Y., 300 #g/ml L-glutamine, 50 U/ml penicillin-G, 50 #g/ml gentamicin, and 25 #M/ml Hepes buffer (Calbiochem, San Diego, Calif.). Responding lymphoeytes (10 ml) were mixed with an equal volume of previously X-irradiated allogeneic stimulator cells and cultured at 37°C in a humidified atmosphere of 5% COz in air. After 7 days viable responding lymphocytes were harvested and used as either effector cell populations in 4 h 5XCr-release assays or placed into long-term culture. H-CTLL were initiated by culturing MLC effector cells in a solution containing 50% human TCGF and 50% supplemented RPMI-1640.
LMCAssay. H-CTLL were tested periodically for continued expression of stimulator specific cytotoxicity as measured in a 4-h 5XCr-release assay. Targets used were either freshly isolated peripheral blood mononuclear cells or long-term T-cell lines. LMC assays were conducted as previously described (7) . Percent specific lysis at varying effeetor/target cell ratios was calculated according to the following equation:
experimental cpm -medium control cpm percent specific lysis=-100 × maximum release cpm --medium control cpm'
Lyric reactivity was detailed in terms of both lytic capacity (LC) and lytic efficiency (LE). LC was defined as the number of lytic units (LU)/10 e CTLL cells. 1 LU was defined as that number of effector cells required to mediate 30% specific lysis. LE was defined as the percent specific lysis observed at an effector/target cell ratio of 100/1.
Co~opreservation. H-CTLL were periodically cryopreserved with the aid of a Planar programmed slow-freeze apparatus (Planar Co., Sunbury on Thames, England). Cultures were prepared for freezing by resuspension in FCS at 4°C and dilution over a 10-min period with an equal volume of RPMI-1640 supplemented with 20% dimethylsulfoxide and 0.2% EDTA.
Frozen human CTLL were maintained in the vapor phase of liquid nitrogen.
Human CTLL Cell Surface Characterization. H-CTLL were tested for their ability to rosette sheep erythrocytes by using methodology previously described (8) .
H-CTLL were also tested for the cell surface expression of both human T-cell antigen and HLA-D or Ia-like determinants. 5~Cr-labeled CTLL cells were used as target cells in antibody-dependent complement-mediated cytolysis assays using absorbed rabbit complement, antigen-specific typing sera, and methodology previously described (7). Both anti-T-cell antigen (A54-5, 10-6) and anti-Ia-like sera (7147-126) were provided by Dr. Jun Minowada, Roswell Park Memorial Institute, Buffalo, N. Y. (9, 10) . Positive control human leukemia cells (MOLT-4F and DAUDI or NALM-1, respectively) were also provided by Dr. Minowada (9) (10) (11) . The cell surface presence of these markers was expressed as the reciprocal of the highest antiserum dilution causing 20% specific lysis.
Results

Cytolytic Reactivity of H-CTLL. H-CTLL-1 was initiated after secondary MLC
stimulation ((A + Bx) + Bx) and has remained in continuous TCGF-dependent culture for 4 too. The continued expression of alloantigen-specific cytolysis by H-CTLL-1 is displayed in Fig. 1 . Effector cell populations depicted include H-CTLL-1 cells tested at the conclusion of MLC stimulation and after 6 and 12 wk of culture. H-CTLL-l-mediated, alloantigen-directed cytotoxicity remained remarkably constant over this 3 mo period. It is important to note that self or third-party target cells were not affected thereby confirming that H-CTLL-l-mediated cytolysis was antigenspecific. Data representing the long-term culture of two additional H-CTLL are shown in Table I . In this experimentation, effector cells were generated in primary 7 day MLC before culture in TCGF-containing medium. The result of LMC assays conducted immediately after MLC and after 4 wk in culture are displayed both in terms of LC and LE. H-CTLL-2 (C + Bx) cells specifically lysed B target cells (410 LU/106) effector cells after 4 wk in culture). Similarly H-CTLL-3 (B + Cx) cells were effective in mediating only the lysis of the allogeneic C target cell.
Co, opreservation of H-CTLL.
The ability to recover cytolytic T cells from the cryopreserved state would greatly facilitate many of the potential uses of H-CTLL (e.g. tissue typing, immunotherapy). Therefore, experiments were designed in which H-CTLL-1 cells were frozen after 4 wk of culture and maintained in the vapor phase 
Cell Surface Characterization of H-CTLL. H-CTLL cells were found to be lymphoblastoid in appearance and 95-100% E-rosette positive. Fig. 2 shows a cytospin preparation of E-rosette positive H-CTLL-1 cells after 11 wk of culture. We also tested H-CTLL-1 cells for the cell membrane expression of two surface markers via antibodydependent complement-mediated cytolysis assays. The two typing sera used included anti-T-LCL antiserum and anti-Ia-like antiserum. Anti-T-LCL antiserum has previously been shown to contain antibody against a normal T-cell antigen (9). Anti-Ialike antiserum was raised in rabbits by immunization with the DAUDI human lymphoblastoid cell line. The DAUDI cell membrane is void of HLA antigens A, B, G I I A . I S E T A L . B R I E F D E F I N I T I V E R E P O R T
ThatE II Stability of H-CTLL Cytolytic Reactivity after Cryopreservation
FIG. 2.
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E-rosettes. Magnification ~ × 5 , 6 0 0 . Table III It is important to note that H-CTLL are thoroughly dependent for proliferation upon the presence of TCGF. TCGF deprivation results in H-CTLL cell death within 24-48 h. Recent studies on murine TCGF have shown that: (a) T cells are required for TCGF production, (b) only T-cell mitogens or antigens elicit TCGF production, and (c) only activated T cells absorb TCGF activity (14) . These observations provide evidence that a specific TCGF acceptor molecule may exist on activated T cells and that TCGF provides a second signal allowing for the expansion of antigen-activated T-cell clones. Although the immunochemical characterization of TCGF is unknown, a similar B-cell second signal soluble factor (the allogeneic effect factor) has been shown to contain Ia gene region determinants (15) . Should TCGF be found to have a similar molecular constituency, a TCGF receptor might help to explain the Ia positive surface characterization of certain murine T-effector cell populations (16) and H-CTLL-1 cells (Table III) .
or C, yet does express an HLA-D encoded glycoprotein (10). The results of the cell surface characterization of H-CTLL-1 cells is detailed in
The fact that differentiated antigen-specific T cells can be maintained in continuous culture suggests that similar mechanisms may exist in vivo which operate to control the proliferation of differentiated effector T cells. Investigators may therefore be able to utilize the in vitro system described here to study the regulation of several T-cell immune responses, particularly through the establishment of functional helper or suppressor human T-cell lines. This approach may provide new insight into the regulation of several immunopathological disease states. It is our belief that further study of differentiated T-cell lines and the effects that regulatory molecules (such as TCGF) mediate upon their reactivity will lead to important new discoveries regarding the mechanism of T-cell-mediated immunity. Summary Long-term cultures of human cytotoxie T-cell lines.(H-CTLL) were established. H-CTLL cells were strictly dependent for growth upon a T-cell growth factor (TCGF) produced by phytohemagglutinin-stimulated normal human peripheral blood lymphocytes. H-CTLL cells were maintained in TCGF-dependent exponential prolifer-ative culture for over 4 mo during which time they continued to mediate stimulator antigen-specific cytotoxieity as measured by a 4-h 51Cr-release assay. H-CTLL cells recovered from cryopreserved stocks and re-established in long-term culture demonstrated similar high levels of antigen-specific cytotoxicity. H-CTLL cells were 95-100% E-rosette positive and expressed normal T and Ia-like cell surface markers. The ability to sustain differentiated antigen-specific T-effector cells in long-term culture may provide a new means for the study of both the mechanism and regulation of T-cellmediated immunity.
